Physician

David Lamar Spencer, M.D.

According to 2025 Medicare claims, David Spencer, M.D. (NPI: 1386842755) practices urology in the Gulfport-Biloxi, MS market, with the plurality of this provider's patient population coming from Jackson, MS. This provider's primary affiliated billing organization is UROLOGY ASSOCIATES OF MOBILE, P.A. (NPI: 1194828368; TIN: 63-0576885) and primary practice location at 39564-3421.

Spencer's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 723 traditional Medicare patients, billed 8,083 HCPCS/CPT codes, and received $306,155 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 2,077 prescription claims across 606 beneficiaries totaling $534,565 in drug costs, led by Erleada (Apalutamide). DME data shows 43 claims. Open Payments data shows 40 records totaling $1,446. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have risen steadily, from $68,964 to $534,565. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $511 and ending at $296.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	906	2,932	$200,210
2016	902	3,166	$229,599
2017	955	3,200	$222,005
2018	902	2,987	$205,693
2019	848	2,480	$175,548
2020	708	1,765	$151,586
2021	722	2,189	$173,326
2022	752	2,330	$170,141
2023	802	8,352	$310,759
2024	723	8,083	$306,155

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	355	1,107	$68,964
2016	349	1,022	$53,699
2017	366	1,030	$51,663
2018	381	1,203	$60,162
2019	387	1,294	$64,189
2020	355	1,150	$57,157
2021	443	1,344	$69,401
2022	581	1,727	$83,766
2023	583	1,828	$83,722
2024	606	2,077	$534,565

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	38	$13,242
2018	N/R	12	$11,733
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	13	$406
2022	N/R	30	$5,156
2023	N/R	39	$12,358
2024	N/R	43	$9,937

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	406	663	$117
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	387	507	$84
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	540	1,039	$11
36415	Insertion of needle into vein for collection of blood sample	157	218	$9
81002	Urinalysis, manual test	199	294	$3

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Erleada	Apalutamide	14	420	$212,225
Orgovyx	Relugolix	64	1,918	$170,264
Myrbetriq	Mirabegron	73	3,150	$46,778
Gemtesa	Vibegron	11	750	$12,035
Tamsulosin Hcl	Tamsulosin Hcl	588	41,126	$8,330

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4351	Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), each	N	N/R	28	$9,641
A4332	Lubricant, individual sterile packet, each	N	N/R	15	$296

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	40	$1,446	Janssen Biotech, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for David Lamar Spencer, M.D.?

Tedicare shows public-source Medicare data for David Lamar Spencer, M.D. (NPI 1386842755), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does David Lamar Spencer, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to David Lamar Spencer, M.D.?

David Lamar Spencer, M.D. is linked to UROLOGY ASSOCIATES OF MOBILE, P.A. (billing NPI 1194828368) in the available physician profile data.

Does David Lamar Spencer, M.D. have Open Payments data?

David Lamar Spencer, M.D. has 40 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.